Sterling commences large-scale production of Nanologica’s silica particles27 Aug 2019
Using Nanologica's technology, Sterling will produce the large volumes of NLAB Saga chromatography material needed by Yunbo Technology to perform preparative chromatography.
Global CDMO, Sterling Pharma Solutions has started large-scale production of Nanologica’s silica particles. Nanologica is a nanotechnology company specialising in the development of silica for application in drug development and chromatography.
The company recently signed a long-term supply agreement with Chinese company, Yunbo Technology allowing Sterling to begin production.
Using Nanologica's technology, Sterling will produce the large volumes of NLAB Saga chromatography material needed by Yunbo Technology to perform preparative chromatography with the first batch expected to be ready for testing during 2020.
Andreas Bhagwani, CEO of Nanologica said: "Sterling has over 50 years of experience in cGMP manufacturing for the pharmaceutical industry and very strong process knowledge and expertise in production.
“We feel very comfortable about co-operating with them for scaling up production to completely different volumes than what we manufacture at our site in Södertälje.”
Nanologica announced in February 2018 that it will start manufacturing preparatory chromatography media used in pharmaceutical manufacturing to 'purify' peptides, specifically insulin. Vastly greater amounts of silica are used in preparative chromatography than in analytical chromatography, where Nanologica is active today.
The first commercial batch is expected to be delivered by Sterling during 2021.
Sterling Pharma Solutions, which has sites in the UK and the US, is a well-established manufacturer of active substances, materials and products for customers in the pharmaceutical industry.
Kevin Cook, CEO of Sterling Pharma Solutions said: “Sterling is delighted to be working with Nanologica on this exciting and innovative opportunity. Sterling has rich experience in development and scale-up of complex synthesis in a fully cGMP environment.
“The combination of the Nanologica expertise and technology, together with Sterling’s manufacturing expertise, provides the required combination for successful commercialisation.”
Nanologica has assessed the preparative chromatography market and believes there is significant potential for growth. The company is planning to expand its presence and customer base within the field facilitated by the start of large-scale manufacturing and being able to provide larger samples to customers for testing.
Thermo Fisher Scientific signs agreement with Lilly Oncology for companion diagnostic
10 Sep 2019
Strategic agreement utilizes FDA-approved next-generation sequencing Oncomine Dx Target Test to identify RET-altered NSCLC and thyroid cancer patients who may be suitable for Lilly's RET inhibitor.Read more
FUJIFILM Irvine Scientific launches BalanCD Gal Supplement for biotherapeutic development
10 Sep 2019
Delivers enhanced galactosylation for improved protein quality, and antibody binding and function.Read more
Drivers behind Saudi Arabia’s forecast 10.74 $billion 2022 market
9 Sep 2019
Growing population, increase in non-communicable diseases and major investment in new hospitals, clinics and treatments driving growth.Read more
Catalent to open new clinical supply facility in San Diego
6 Sep 2019
Will enhance speed to clinic through expanded early-phase clinical supply and oral dose development services.Read more
Take part in pharma’s largest reputation survey
6 Sep 2019
Use your voice to shape CPhI Worldwide's third annual global survey of the major trends, changes and developments in the industry.Read more
BioCity backs world's first Rx to OTC switch incubator
5 Sep 2019
Maxwellia considered to have the skills and the expertise to deliver and reach their goal of creating the big OTC brands of the future.Read more
Velesco Pharma to triple its clinical manufacturing capacity
4 Sep 2019
Company's new building in Wixom, MI replace and consolidate its existing manufacturing site in Kalamazoo, MI.Read more
Taiwan's biggest CDMO secures FDA approval
3 Sep 2019
Customers claim Bora's oral solid dosage Zhunan facility is in the top 5 external manufacturing facilities they’ve ever visited in the world.Read more
China relaxes import regulations to improve access and availability of affordable medicines
3 Sep 2019
The potential for generics to support the healthcare needs of China is significant.Read more
Dutch company receives €20 million for skin cancer diagnostic test
3 Sep 2019
The test can accurately predict the risk of having metastases present in the lymph nodes without having to undergo surgery to remove lymph nodes.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation